模块化44Ti/44Sc发生器的构建:临床前模型中的洗脱液评价及人体辐射剂量估算
研究构建并评价了临床规模的模块化44Ti/44Sc发生器,在雌性Swiss Webster小鼠中比较44ScCl3、[44Sc]-柠檬酸盐和[44Sc]-NODAGA的药代动力学,并基于生物分布数据用IDAC-Dose软件估算44ScCl3在人体成人18个器官和组织的吸收剂量。
要点
- 44Ti上样产率99.97%,44ScCl3以0.05 M HCl洗脱典型产率为82.9 ± 5.3%(N = 16)。
- 加用可更换二级ZR树脂柱后,44Sc/44Ti比值从1038 ± 440提升至3557 ± 680(Bq/Bq)。
- 游离44Sc在循环中停留显著长于螯合44Sc,所致辐射负担约为稳定螯合44Sc的10倍。
核心结论
- 开发了模块化设计的临床规模44Ti/44Sc发生器系统,可以0.05 M HCl供应44ScCl3,适合进一步放射性标记和体内使用。
- 数据表明游离44ScCl3在循环中停留时间延长,导致辐射负担约为稳定螯合44Sc的10倍,稳定的44Sc/47Sc络合更有利于体内应用和临床使用。
研究设计与样本
- 将101.2 MBq的44Ti/44Sc溶于6 M HCl装载到含ZR树脂的模块化发生器中,用0.05 M HCl洗脱44Sc。
- 在雌性Swiss Webster小鼠中进行PET显像和离体生物分布研究,比较44ScCl3、[44Sc]-柠檬酸盐和[44Sc]-NODAGA。
- 基于生物分布数据,用IDAC-Dose软件计算44/47ScCl3在成人18个器官和组织的吸收剂量。
主要发现
- 6 M HCl中的44Ti装载到有机树脂发生器的产率为99.97%。
- 装载和初始稳定后,44ScCl3以0.05 M HCl洗脱的典型产率为82.9 ± 5.3%(N = 16),该产率归一化至估算的发生器容量。
- 正向和反向运行时,在流出口采用可更换的二级ZR树脂柱后,一级柱的44Sc/44Ti比值从1038 ± 440显著改善至3557 ± 680(Bq/Bq)。
- 44ScCl3、[44Sc]-柠檬酸盐和[44Sc]-NODAGA的体内显像和离体分布研究显示,游离44Sc在循环中停留显著长于螯合44Sc。
- 44ScCl3的剂量估算显示,70 kg成年男性辐射负担为0.146 mSv/MBq,57 kg成年女性为0.179 mSv/MBq;成年男性肝脏、脾脏和心壁吸收剂量最高,分别为0.524、0.502和0.303 mGy/MBq。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 44Sc/47Sc is an attractive theranostic pair for targeted in vivo positron emission tomographic (PET) imaging and beta-particle treatment of cancer. The 44Ti/44Sc generator allows daily onsite production of this diagnostic isotope, which may provide an attractive alternative for PET facilities that lack in-house irradiation capabilities. Early animal and patient studies have demonstrated the utility of 44Sc. In our current study, we built and evaluated a novel clinical-scale 44Ti/44Sc generator, explored the pharmacokinetic profiles of 44ScCl3, [44Sc]-citrate and [44Sc]-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid) in naïve mice, and estimated the radiation burden of 44ScCl3 in humans. METHODS: 44Ti/44Sc (101.2 MBq) in 6 M HCl solution was utilized to assemble a modular ZR resin containing generator. After assembly, 44Sc was eluted with 0.05 M HCl for further PET imaging and biodistribution studies in female Swiss Webster mice. Based on the biodistribution data, absorbed doses of 44/47ScCl3 in human adults were calculated for 18 organs and tissues using the IDAC-Dose software. RESULTS: 44Ti in 6 M HCl was loaded onto the organic resin generator with a yield of 99.97%. After loading and initial stabilization, 44ScCl3 was eluted with 0.05 M HCl in typical yields of 82.9 ± 5.3% (N = 16), which was normalized to the estimated generator capacity. Estimated generator capacity was computed based on elution time interval and the total amount of 44Ti loaded on the generator. Run in forward and reverse directions, the 44Sc/44Ti ratio from a primary column was significantly improved from 1038 ± 440 to 3557 ± 680 (Bq/Bq) when a secondary, replaceable, ZR resin cartridge was employed at the flow outlet. In vivo imaging and ex vivo distribution studies of the reversible modular generator for 44ScCl3, [44Sc]-citrate and [44Sc]-NODAGA show that free 44Sc remained in the circulation significantly longer than the chelated 44Sc. The dose estimation of 44ScCl3 reveals that the radiation burden is 0.146 mSv/MBq for a 70 kg adult male and 0.179 mSv/MBq for a 57 kg adult female. Liver, spleen and heart wall will receive the highest absorbed dose: 0.524, 0.502, and 0.303 mGy/MBq, respectively, for the adult male. CONCLUSIONS: A clinical-scale 44Ti/44Sc generator system with a modular design was developed to supply 44ScCl3 in 0.05 M HCl, which is suitable for further radiolabeling and in vivo use. Our data demonstrated that free 44ScCl3 remained in the circulation for extended periods, which resulted in approximately 10 times greater radiation burden than stably chelated 44Sc. Stable 44Sc/47Sc-complexation will be more favorable for in vivo use and for clinical utility.
引用
- Benabdallah N, Zhang H, Unnerstall R, et al. Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry. EJNMMI Res. 2023. PMID: 36853422. doi:10.1186/s13550-023-00968-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。